Hypertonic induction of COX-2 expression in renal medullary epithelial cells requires transactivation of the EGFR

Am J Physiol Renal Physiol. 2003 Aug;285(2):F281-8. doi: 10.1152/ajprenal.00030.2003. Epub 2003 Apr 1.

Abstract

Hypertonic stress increases expression of cyclooxygenase-2 (COX-2) in renal medullary epithelial and interstitial cells. Because hypertonic COX-2 expression is, in part, sensitive to inhibition of the ERK MAPK, an effector of activated receptor tyrosine kinases such as the EGF receptor, we investigated a role for this receptor in signaling to COX-2 expression. Hypertonic stress increased COX-2 expression at the mRNA and protein levels at 6 and 24 h of hypertonic treatment. Two potent, specific inhibitors of the EGF receptor kinase, AG-1478 and PD-153035, abrogated this effect. These inhibitors also blocked the ability of hypertonic stress to increase PGE2 release; in addition, they partially blocked tonicity-dependent phosphorylation of ERK but not of the related MAPKs, JNK or p38. Pharmacological inhibition of ERK activation partially blocked tonicity-dependent COX-2 expression. Hypertonic induction of COX-2 was likely transcriptionally mediated, as NaCl stress increased luciferase reporter gene activity under control of the human COX-2 promoter, and this effect was also sensitive to inhibition of the EGF receptor kinase. Metalloproteinase action is required for transactivation of the EGF receptor. Pharmacological inhibition of metalloproteinase function blocked tonicity-inducible COX-2 expression. Furthermore, the effect of hypertonicity on COX-2 expression was also evident in the EGF-responsive Madin-Darby canine kidney and 3T3 cell lines but was virtually absent from the EGF-unresponsive (and EGF receptor null) Chinese hamster-derived CHO cell line. Taken together, these data indicate that hypertonicity-dependent COX-2 expression in medullary epithelial cells requires transactivation of the EGF receptor and, potentially, ectodomain cleavage of an EGF receptor ligand.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Butadienes / pharmacology
  • CHO Cells
  • Cricetinae
  • Cyclooxygenase 2
  • Dogs
  • Enzyme Inhibitors / pharmacology
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Epithelial Cells / enzymology
  • ErbB Receptors / metabolism*
  • Flavonoids / pharmacology
  • Gene Expression Regulation, Enzymologic / drug effects
  • Gene Expression Regulation, Enzymologic / physiology*
  • Isoenzymes / genetics*
  • Kidney Medulla / cytology
  • Kidney Medulla / metabolism*
  • Nitriles / pharmacology
  • Prostaglandin-Endoperoxide Synthases / genetics*
  • RNA, Messenger / metabolism
  • Saline Solution, Hypertonic / pharmacology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Water-Electrolyte Balance / genetics*

Substances

  • Butadienes
  • Enzyme Inhibitors
  • Flavonoids
  • Isoenzymes
  • Nitriles
  • RNA, Messenger
  • Saline Solution, Hypertonic
  • U 0126
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • ErbB Receptors
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one